Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: J Urol. 2012 Oct 9;189(4):1415–1420. doi: 10.1016/j.juro.2012.10.002

Table 5.

Discontinuation rates by treatment group and dose

Treatment Group Single Dose Double Dose Triple Dose Total p-value*
Discontinuation for Any Reason [N (%)]
Saw palmetto 4 (2.3%) 8 (4.6%) 1 (0.6%) 13 (7.5%) 0.39
Placebo 2 (1.1%) 6 (3.3%) 1 (0.6%) 9 (5.0%)
Discontinuation for Adverse Event [N (%)]
Saw palmetto 1 (0.6%) 1 (0.6%) 0 (0%) 2 (1.2%) 0.25
Placebo 0 (0%) 0 (0%) 0 (0%) 0 (0%)
*

p-value for comparison of Saw palmetto vs. placebo groups by Fisher’s exact test